Blue and green emission-transformed fluorescent copolymer: Specific detection of levodopa of anti-Parkinson drug in human serum

Electrochemical identification of reductive enantiomers in wood channels: A low-cost and scalable platform for chiral sensing

Chirality, an inherent characteristic of natural substances (such as sugars, peptides, proteins, and nucleic acid), plays a vital role in human metabolism and exerts substantial impacts. In general, chiral drugs can display diverse pharmacological and pharmacokinetic properties. One enantiomer may exhibit therapeutic effects, while the other could cause adverse reactions. Selective recognition of enantiomers is thus a significant task in the biomolecular and pharmaceutical fields. Despite the development of several chiral identification techniques, low-cost enantioselective sensing methods remain highly desirable. Here, we designed and developed an electrochemical sensing device for reductive enantiomer identification using natural wood channels as the substrate. The wood channels were endowed with oxidase-like activity through the in-situ growth of cerium oxide nanoparticles (CeO2). Chiral recognition capability was further introduced by incorporating a layer of chiral ZIF-8 (L-ZIF) as the chiral selector. To demonstrate the enantioselective sensing performance, 3,4-dihydroxyphenylalanine (DOPA) enantiomers were employed as model analytes. Due to the oxidase-like activity and the confinement effect of the proposed channels, the captured DOPA enantiomers were effectively oxidized to their quinone structure, and the Ce(IV) in CeO2 was reduced to Ce(III). These changes led to alterations in the surface charge of the channels, thereby modulating their ionic transport properties. This sensing mechanism also proved useful for the identification of other reductive enantiomers. The limits of detection for l-DOPA and d-DOPA were determined as 2.41 nM and 1.56 nM, respectively. The resulting wood channel-based sensing device not only can be used for the recognition and detection of reductive enantiomers, but also is expected to be applied to the non-electochemically active substances. Moreover, this study offers a novel type of solid-state channel material with low cost, reproducibility, and easy accessibility for electrochemical chiral sensing.

Physicochemically modulated fluorescence-scattering ratiometric sensor for selective and visual detection of levodopa

In this study, a facile fluorescence-scattering ratiometric sensor was designed for visual and selective detection of levodopa (LD) via a clever physicochemical modulation scheme. The alkalized products of LD can rapidly react with polyethyleneimine (PEI) to exhibit an intense blue fluorescence and decrease the second-order scattering (SOS) signal of PEI. As the concentration of LD increased, the fluorescence intensity at 420 nm increased and the SOS intensity at 675 nm decreased synchronously. Thus the fluorescence-scattering ratiometric sensor was constructed by virtue of the two simultaneously changed signals. Furthermore, red light-emitting Au nanoclusters (AuNCs) were added into the above mixture solution to enlarge the SOS signal and provide a stable red background fluorescence. The intensity ratio of fluorescence to SOS (F/(S/Sblank)) is linear dependent on CLD in the wide range of 50.0---30000.0 nM, and LD as low as 50.0 nM can be identified with the naked eye via change of fluorescence color. The developed ratiometric sensor is smart, simple and efficient, and has been applied to the convenient assay of LD in real samples. The proposed physicochemical modulation strategy provides a new and facile path for selectively and visually identifying the target from its analogues.

Ce(IV)-coordinated organogel-based assay for on-site monitoring of propyl gallate with turn-on fluorescence signal

Propyl gallate (PG) is a commonly used synthetic phenolic antioxidant in foodstuffs and industrial products. Due to the potential health risk of PG, rapid and on-site detection in food and environment samples are important to guarantee human health. Herein, we demonstrated rapid monitoring of PG by a fluorescence turn-on strategy based on a specific fluorogenic reaction between PG and polyethyleneimine (PEI). Specifically, Ce4+ with oxidase-mimicking activity oxidized PG to its oxides, which then reacted with PEI through the Michael addition to generate the fluorescent compound. The proposed fluorogenic reaction had good specificity for PG, which could distinguish PG from other phenolic antioxidants and interferences. Furthermore, portable and low-cost organogel test kits were prepared using poly(ethylene glycol) diacrylate for quantitative and on-site detection of PG via a smartphone-based sensing platform. The organogel-based assay detection limit was 1.0 μg mL-1 with recoveries ranging from 80.2% to 106.2% in edible oils and surface water. Suitability of the developed assay was also validated by high-performance liquid chromatography. Our study provides an effective fluorescent approach to rapid, specific, and convenient monitoring of PG, which is useful for diminishing the risk of PG exposure.

A bacterial cellulose-based LiSrVO4:Eu3+ nanosensor platform for smartphone sensing of levodopa and dopamine: point-of-care diagnosis of Parkinson's disease

Among the catecholamines, dopamine (DA) is essential in regulating multiple aspects of the central nervous system. The level of dopamine in the brain correlates with neurological diseases such as Parkinson's disease (PD). However, dopamine is unable to cross the blood-brain barrier (BBB). Therefore, levodopa (LD) is used to restore normal dopamine levels in the brain by crossing the BBB. Thus, the control of LD and DA levels is critical for PD diagnosis. For this purpose, LiSr0.0985VO4:0.015Eu3+ (LSV:0.015Eu3+) nanoplates were synthesized by the microwave-assisted co-precipitation method, and have been employed as an optical sensor for the sensitive and selective detection of catecholamines. The synthesized LSV:0.015Eu3+ nanoplates emitted red fluorescence with a high quantum yield (QY) of 48%. By increasing the LD and DA concentrations, the fluorescence intensity of LSV:0.015Eu3+ nanoplates gradually decreased. Under optimal conditions, the linear dynamic ranges were 1-40 μM (R2 = 0.9972) and 2-50 μM (R2 = 0.9976), and the detection limits (LOD) were 279 nM, and 390 nM for LD and DA, respectively. Herein, an instrument-free, rapid quantification visual assay was developed using a paper-based analytical device (PAD) with LSV:0.015Eu3+ fixed on the bacterial cellulose nanopaper (LEBN) to determine LD and DA concentrations with ease of operation and low cost. A smartphone was coupled with the PAD device to quantitatively analyze the fluorescence intensity changes of LSV:0.015Eu3+ using the color recognizer application (APP). In addition, the LSV:0.015Eu3+ nanosensor showed acceptable repeatability and was used to analyze real human urine, blood serum, and tap water samples with a recovery of 96-107%.

Green Synthesis of Sulfur- and Nitrogen-Doped Carbon Quantum Dots for Determination of L-DOPA Using Fluorescence Spectroscopy and a Smartphone-Based Fluorimeter

Sulfur- and nitrogen-doped carbon quantum dots (S,N-CQDs) were synthesized using feijoa leaves as a green precursor via a novel route. Spectroscopic and microscopic methods such as X-ray photoelectron spectroscopy, fluorescence spectroscopy, and high-resolution transmission electron microscopy were used to analyze the synthesized materials. The blue emissive S,N-CQDs were applied for qualitative and quantitative determination of levodopa (L-DOPA) in aqueous environmental and real samples. Human blood serum and urine were used as real samples with good recovery of 98.4-104.6 and 97.3-104.3%, respectively. A smartphone-based fluorimeter device was employed as a novel and user-friendly self-product device for pictorial determination of L-DOPA. Bacterial cellulose nanopaper (BC) was used as a substrate for S,N-CQDs to make an optical nanopaper-based sensor for L-DOPA determination. The S,N-CQDs demonstrated good selectivity and sensitivity. The interaction of L-DOPA with the functional groups of the S,N-CQDs via the photo-induced electron transfer (PET) mechanism quenched the fluorescence of S,N-CQDs. The PET process was studied using fluorescence lifetime decay, which confirmed the dynamic quenching of S,N-CQD fluorescence. The limit of detection (LOD) of S,N-CQDs in aqueous solution and the nanopaper-based sensor was 0.45 μM in the concentration range of 1-50 μM and 31.05 μM in the concentration range of 1-250 μM, respectively.

Closing the loop for patients with Parkinson disease: where are we?

Although levodopa remains the most efficacious symptomatic therapy for Parkinson disease (PD), management of levodopa treatment during the advanced stages of the disease is extremely challenging. This difficulty is a result of levodopa's short half-life, a progressive narrowing of the therapeutic window, and major inter-patient and intra-patient variations in the dose-response relationship. Therefore, a suitable alternative to repeated oral administration of levodopa is being sought. Recent research efforts have focused on the development of novel levodopa delivery strategies and wearable physical sensors that track symptoms and disease progression. However, the need for methods to monitor the levels of levodopa present in the body in real time has been overlooked. Advances in chemical sensor technology mean that the development of wearable and mobile biosensors for continuous or frequent levodopa measurements is now possible. Such levodopa monitoring could help to deliver personalized and timely medication dosing to alleviate treatment-related fluctuations in the symptoms of PD. Therefore, with the aim of optimizing therapeutic management of PD and improving the quality of life of patients, we share our vision of a future closed-loop autonomous wearable 'sense-and-act' system. This system consists of a network of physical and chemical sensors coupled with a levodopa delivery device and is guided by effective big data fusion algorithms and machine learning methods.

A strategy to differentiate dopamine and levodopa based on their cyclization reaction regulated by pH

Levodopa is often used to treat Parkinson's disease. It coexists with dopamine in human fluids and is electrochemically oxidized at the same potential as dopamine. Differentiating levodopa from dopamine is difficult via electrochemical techniques. Taking advantage of the differences in the rate constants of levodopa and dopamine for the intramolecular cyclization reaction, we observed that the cyclization reaction of dopamine-quinone was completely suppressed under pH 4.8, while that of levodopa-quinone occurred. The product of cyclization caused a new cathodic peak at negative potential. Its peak current was dependent on the concentration of levodopa but not that of dopamine. As a result, we developed a method of detecting levodopa in the presence of dopamine with a bare glassy carbon electrode.

Glutathione-decorated fluorescent carbon quantum dots for sensitive and selective detection of levodopa

Levodopa has been a standard drug for treating Parkinson's disease since the 1960s, but it has caused many side effects such as wearing-off, motor fluctuation, and dystonia. In this work, we developed glutathione-conjugated carbon quantum dots (GSH-CQDs) as a novel fluorescent sensor for sensitive and selective detection of levodopa. The GSH-CQDs were prepared by EDC/NHS coupling reaction of glutathione (GSH) with amine-functionalized CQDs (N-CQDs) synthesized using meta-phenylenediamine and ethylenediamine. The synthesized GSH-CQDs emitted bright green fluorescence with a high quantum yield (QY) of 22.42 ± 6.88%. However, upon the addition of levodopa to GSH-CQDs under alkaline conditions, the fluorescence of GSH-CQDs was quenched. Since levodopa is converted to dopaquinone in an alkaline environment, it is presumed that thiol groups of GHS-CQDs form covalent bonds with dopaquinone, causing fluorescence quenching through photoinduced electron transfer. Therefore, as the concentration of levodopa increased, the fluorescence intensity of GSH-CQDs was gradually decreased. Under optimal conditions, a linear response was observed in the range of 0.05-1 μM, and limit of detection (LOD) was determined to be 0.057 μM. The GSH-CQDs exhibited high specificity to levodopa over other non-target biological substances, quinone derivatives, and Parkinson's medications. Furthermore, the capability of this GSH-CQDs sensor for monitoring levodopa in human serum were validated with excellent precision and recovery rates of 100.20-103.33%.

Fluorescence copolymer-based dual-signal monitoring tyrosinase activity and its inhibitor screening via blue-green emission transformation

Tyrosinase (TYR) is a crucial enzyme in melanin metabolism and catecholamine production, its abnormal overexpression is closely associated with many human diseases involving melanoma cancer, vitiligo, Parkinson's disease and so on. Herein, a dual-signal fluorescence sensing system for monitoring TYR activity is constructed depending on the transformation of blue-green fluorescence emission of copolymer. The developed sensing system is based on TYR catalyzing the hydroxylation of mono-phenol to o-diphenol and the conversion of fluorescence copolymer (FCP) blue emission (430 nm) and green emission (535 nm) in the presence of PEI. In the system, both blue and green emission exhibit a high selectivity and sensitivity (S/B up to 300 and 30 for blue and green emission, respectively) toward TYR in the range from 0.5 to 2.5 U/mL with the detection limit of 0.002 U/mL and 0.06 U/mL, respectively. Additionally, this assay is used to detect TYR in human serum with excellent recovery even at 30% human serum concentrations. Furthermore, it still has been successfully applied to TYR inhibitor screening by taking kojic acid as a model. We believe that our developed sensor has great potential application in TYR-associated disease diagnosis and treatment and drug discovery.

Novel synthesis of a dual fluorimetric sensor for the simultaneous analysis of levodopa and pyridoxine

Herein, a fluorimetric sensor was fabricated based on molecularly imprinted polymers (MIPs) with two types of carbon dots as fluorophores. The MIPs produced had similar excitation wavelengths (400 nm) and different emission wavelengths (445 and 545 nm). They were used for the simultaneous analysis of levodopa and pyridoxine. First, two types of carbon dots, i.e. nitrogen-doped carbon dots (NCDs) with a quantum yield of 43%, and carbon dots from o-phenylenediamine (O-CDs) with a quantum yield of 17%, were prepared using the hydrothermal method. Their surfaces were then covered with MIPs through the reverse microemulsion method. Finally, a mixture of powdered NCD@MIP and O-CD@MIP nanocomposites was used for the simultaneous fluorescence measurement of levodopa and pyridoxine. Under optimal conditions using response surface methodology and Design-Expert software, a linear dynamic range of 38 to 369 nM and 53 to 457 nM, and detection limits of 13 nM and 25 nM were obtained for levodopa and pyridoxine, respectively. The capability of the proposed fluorimetric sensor was investigated in human blood serum and urine samples. Graphical Abstract Schematic representation of nitrogen-doped carbon dots (NCDs), carbon dots from o-phenylenediamine (O-CDs), NCDs coated with imprinted polymers (NCD@MIPs), and O-CDs coated with imprinted polymers (O-CD@MIPs) in the presence and absence of levodopa and pyridoxine.